Table 1

 Assessment of response to all clinical measures after 54 and 102 weeks of treatment for all 52 patients who participated in the second year study

AssessmentBaselineWeek 54Week 102p Value
wk 0 v wk 102wk 54 v wk 102
Results are shown as mean (SD) unless otherwise stated.
Global disease assessment (VAS)
    Patient (0–10 cm)6.9 (1.9)2.8 (1.9)2.6 (2.0)<0.00010.39
    Physician (0–10 cm)6.3 (1.6)2.2 (1.5)2.0 (1.4)<0.00010.14
BASDAI6.4 (1.4)2.5 (1.7)2.6 (2.0)<0.00010.61
BASFI5.2 (1.9)3.0 (2.2)3.0 (2.2)<0.00010.88
BASMI3.8 (2.0)2.4 (2.0)2.7 (2.1)<0.00010.038
CRP (mg/l), median (range)21.5 (0.9–74.0)3.9 (0–17.8)4.3 (0–42.7)<0.00010.51
ESR (mm/1st h), median (range)25.0 (3–88)8.0 (1–70)7.5 (2–70)<0.00010.39
SF-36
    Physical component29.3 (7.0)40.6 (10.6)40.9 (11.1)<0.00010.73
    Mental component42.3 (12.2)50.9 (8.9)50.2 (9.5)<0.00010.47